CA2460150A1 - Matieres et procedes pour le traitement de diabetes, de l'hyperlipidemie, de l'hypercholesterolemie, et de l'atherosclerose - Google Patents
Matieres et procedes pour le traitement de diabetes, de l'hyperlipidemie, de l'hypercholesterolemie, et de l'atherosclerose Download PDFInfo
- Publication number
- CA2460150A1 CA2460150A1 CA002460150A CA2460150A CA2460150A1 CA 2460150 A1 CA2460150 A1 CA 2460150A1 CA 002460150 A CA002460150 A CA 002460150A CA 2460150 A CA2460150 A CA 2460150A CA 2460150 A1 CA2460150 A1 CA 2460150A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- compounds
- ring
- group
- optionally
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Abstract
L'invention concerne des composés pharmaceutiques utiles dans le traitement des diabètes de type II. Ces composés sont avantageux parce qu'ils sont facilement métabolisés par les systèmes de désintoxication de substances métaboliques. L'invention concerne en particulier des analogues de thiazolidinedione conçus pour comprendre des esters à l'intérieur de la structure de ces composés. L'invention concerne également des procédés de traitement de troubles, notamment de diabètes, comprenant l'administration de compositions thérapeutiquement efficaces comprenant des composés conçus pour être métabolisés par des hydrolases et des estérases intracellulaires ou de sérum. L'invention concerne encore des compositions pharmaceutiques d'analogues de thiazolidinedione contenant des esters.
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/961,538 | 2001-09-21 | ||
US09/961,542 | 2001-09-21 | ||
US09/961,542 US6768008B2 (en) | 2000-04-24 | 2001-09-21 | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis |
US09/961,538 US6784199B2 (en) | 2000-09-21 | 2001-09-21 | Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals |
US10/228,670 US20030054974A1 (en) | 2001-08-24 | 2002-08-26 | Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof |
US10/228,670 | 2002-08-26 | ||
PCT/US2002/030017 WO2003024943A2 (fr) | 2000-04-24 | 2002-09-20 | Matieres et procedes pour le traitement de diabetes, de l'hyperlipidemie, de l'hypercholesterolemie, et de l'atherosclerose |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2460150A1 true CA2460150A1 (fr) | 2003-03-27 |
Family
ID=49447234
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002460150A Abandoned CA2460150A1 (fr) | 2001-09-21 | 2002-09-20 | Matieres et procedes pour le traitement de diabetes, de l'hyperlipidemie, de l'hypercholesterolemie, et de l'atherosclerose |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1430039A2 (fr) |
JP (1) | JP2005527475A (fr) |
KR (1) | KR20040062545A (fr) |
CA (1) | CA2460150A1 (fr) |
NZ (1) | NZ532261A (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100829468B1 (ko) * | 2007-01-17 | 2008-05-16 | 한국화학연구원 | 신규한 1,2,4-티아다이아졸리딘-3,5-다이온 화합물 및 이의제조방법 |
-
2002
- 2002-09-20 NZ NZ532261A patent/NZ532261A/en unknown
- 2002-09-20 KR KR10-2004-7004172A patent/KR20040062545A/ko not_active Application Discontinuation
- 2002-09-20 JP JP2003528791A patent/JP2005527475A/ja not_active Withdrawn
- 2002-09-20 EP EP02763686A patent/EP1430039A2/fr not_active Withdrawn
- 2002-09-20 CA CA002460150A patent/CA2460150A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
NZ532261A (en) | 2006-02-24 |
JP2005527475A (ja) | 2005-09-15 |
KR20040062545A (ko) | 2004-07-07 |
EP1430039A2 (fr) | 2004-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6768008B2 (en) | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis | |
CA2457054C (fr) | Activateur du recepteur .delta. sensible au proliferateur de peroxysome | |
EP1480642B1 (fr) | Modulateurs des r cepteurs activ s par les prolif rateurs de peroxisomes | |
JP3490704B2 (ja) | チアゾールおよびオキサゾール誘導体ならびにそれらの医薬的使用 | |
JP2005529077A (ja) | ペルオキシソーム増殖因子活性化受容体調節物質 | |
Reddy et al. | Novel antidiabetic and hypolipidemic agents. 5. Hydroxyl versus benzyloxy containing chroman derivatives | |
JP2000514041A (ja) | 抗糖尿病、低脂血、抗高血圧特性を有するチアゾリジンジオン化合物、それらの調製法、及びその薬学的組成物 | |
Lohray et al. | Novel euglycemic and hypolipidemic agents. 4. Pyridyl-and quinolinyl-containing thiazolidinediones | |
JPH10194970A (ja) | 置換チアゾリジンジオン誘導体を含む抗高脂血剤 | |
KR20050119201A (ko) | 5원 헤테로방향족 고리 화합물 및 이의 의약적 용도 | |
JP2006514069A (ja) | Ppar調節因子としての融合複素環式誘導体 | |
US6784199B2 (en) | Isoxazolidine compounds useful in the treatment of diabetes, hyperlipidemia, and atherosclerosis in mammals | |
ES2364150T3 (es) | Derivados del ácido butanoico, procesos para su preparación, composiciones farmacéuticas que los comprenden y sus aplicaciones terapéuticas. | |
US6680387B2 (en) | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis | |
US6958355B2 (en) | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis | |
CA2402123A1 (fr) | Compositions et methodes destinees au traitement du diabete, de l'hyperlipidemie, de l'hypercholesterolemie et de l'atherosclerose | |
WO2006117743A1 (fr) | Composes aromatiques substitues, agents anti-diabetiques | |
US20060047000A1 (en) | Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis | |
CA2460150A1 (fr) | Matieres et procedes pour le traitement de diabetes, de l'hyperlipidemie, de l'hypercholesterolemie, et de l'atherosclerose | |
AU2002327683A1 (en) | Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis | |
EP1207156B1 (fr) | Derives de benzylthiazolidine-2,4-dione substitues | |
ZA200401945B (en) | Aryl derivatives for the treatment of diabetes, hyperlipidemia, hypercholesterolemia and atherosclerosis. | |
Shinkai et al. | 4-(trans-4-Methylcyclohexyl)-4-oxobutyric acid (JTT-608). A new class of antidiabetic agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |